Page last updated: 2024-10-26

dyclonine and Breast Cancer

dyclonine has been researched along with Breast Cancer in 1 studies

Research Excerpts

ExcerptRelevanceReference
" Taking advantage of the knowledge gained from Saccharomyces cerevisiae, we show that dyclonine and alverine citrate, the major components of two over-the-counter medicines, can substantially enhance the cytotoxic effects of proteasome inhibitor MG132 on breast cancer cells."7.75Dyclonine and alverine citrate enhance the cytotoxic effects of proteasome inhibitor MG132 on breast cancer cells. ( Ju, D; Wang, X; Xie, Y, 2009)
" Taking advantage of the knowledge gained from Saccharomyces cerevisiae, we show that dyclonine and alverine citrate, the major components of two over-the-counter medicines, can substantially enhance the cytotoxic effects of proteasome inhibitor MG132 on breast cancer cells."3.75Dyclonine and alverine citrate enhance the cytotoxic effects of proteasome inhibitor MG132 on breast cancer cells. ( Ju, D; Wang, X; Xie, Y, 2009)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ju, D1
Wang, X1
Xie, Y1

Other Studies

1 other study available for dyclonine and Breast Cancer

ArticleYear
Dyclonine and alverine citrate enhance the cytotoxic effects of proteasome inhibitor MG132 on breast cancer cells.
    International journal of molecular medicine, 2009, Volume: 23, Issue:2

    Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Enzyme Inhibitors; Female; Humans; Leupep

2009